Editor of Patient Care Online.
Global Study Builds on Previous Research Linking Semaglutide & Suicide: Daily Dose
Your daily dose of the clinical news you may have missed.
CPAP Treatment and Hypertensive Adverse Outcomes in Pregnancy: Daily Dose
Many Patients with Chronic Hand Eczema Report Having Corticosteroid Phobia, Shows New Research
In a study of patients with CHE, 75.5% of participants totally or almost agreed that topical corticosteroids cause damage to skin.
Updated mRNA COVID-19 Vaccines: Daily Dose
Finerenone Improves Outcomes in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction
ESC 2024: Findings from the FINEARTS-HF clinical trial provide the first definite evidence that an MRA can be beneficial in patients with HFmrEF/HFpEF.
Regular Aspirin Use for CRC Prevention Found to Benefit Unhealthy Adults Most: Daily Dose
FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
Tirzepatide Reduces Risk for Progression from Prediabetes to T2D: Daily Dose
Recreational Drug Users Face Triple the Risk of Repeat Major Adverse CV Events vs Non-Users
ESC 2024: Cannabis, opioid, and MDMA use were most strongly tied to cardiovascular event risk, according to a new study.
Geography May Matter in Dementia Diagnosis: Daily Dose
PTSD and Risk of Poor T2D Outcomes in Veterans: Daily Dose
T2D, Prediabetes Accelerate Brain Aging, but Healthier Lifestyle May Counteract the Association
Type 2 diabetes and prediabetes were associated with accelerated brain aging, particularly among men and persons with poor cardiometabolic health, according to new research.
New Findings Underscore Importance of Mental Health Screening in Adolescents Receiving Obesity Treatment
In a study of adolescents with obesity, symptoms of depression and eating disorders decreased over the course of a 52-week intensive behavioral intervention.
Global Disparities in Cancer Cases, Deaths Among Men: Daily Dose
FDA Clears Tubeless Automated Insulin-Delivery System for Adults with Type 2 Diabetes
The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.
Suicide Rates in US Preteens: Daily Dose
Semaglutide & Suicide: Large Analysis from WHO Data Builds on Previous Research Linking the Two
Results of a global analysis of over 30 million cases showed significantly higher odds for suicidal ideation among adults who received semaglutide vs other medications.
Plant-Based Fats Reduce Risk for Overall, CVD Death: Daily Dose
Respiratory Virus Vaccines: A Q&A With AAFP President Steven Furr, MD
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
Tirzepatide Tied to Lower Risk for Death, Adverse CV and Kidney Outcomes vs GLP-1s: Daily Dose
Obesity in the Time of COVID: Expert Insights on the Physical, Emotional Toll on Patients
Patients with obesity face both physical and emotional challenges during the COVID-19 pandemic. How can PCPs help?
FDA Grants Approval, EUA for Updated mRNA COVID-19 Vaccines
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
Bayer: Phase 2 Trial of Investigational Soluble Guanylate Cyclase Activator for Chronic Kidney Disease Begins
The sGC activator represents a novel approach to modulating the nitric oxide-soluble sGC-cyclic guanosine monophosphate pathway.
Effectiveness of Anti-Obesity Drugs for CVD Prevention: A Clinician Discussion
Anila Chadha, MD, talks to Patient Care about how antiobesity medications can aid in reducing CVD risk in patients with obesity.
PCP Visits After Cancer Surgery May Lower Mortality Risk in Older Adults: Daily Dose
Aspirin Use for Colorectal Cancer Prevention May Benefit Unhealthy Individuals Most
Regular aspirin use was associated with a greater absolute reduction in CRC incidence among adults with unhealthier lifestyles, according to recent research.
FDA Approves Neffy as First Nasal Spray for Allergic Reactions: Daily Dose
Cardiovascular Disease Prevention in Patients with Obesity: An Expert Perspective
Anila Chadha, MD, highlights key preventive strategies to reduce CVD risk in patients with obesity and how to tailor them to address individual patient needs.
First At-Home, OTC Syphilis Test Granted Marketing Authorization by FDA
The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.
Cancer Deaths Among Men Projected to Increase 93% Globally by 2050, According to New Data
Researchers observed substantial disparities in burden by cancer type, age group, countries/territories, and a country's level of Human Development Index.
